Why the study?
The role and mechanisms of mitochondrial ferritin-mediated ferroptosis in the development of post-myocardial infarction ventricular arrhythmias were not well understood.
Does mitochondrial ferritin inhibition or ferroptosis inhibition affect vulnerability to post-myocardial infarction ventricular arrhythmias in preclinical models?
Does mitochondrial ferritin inhibition or ferroptosis inhibition affect vulnerability to post-myocardial infarction ventricular arrhythmias in preclinical models?
Mitochondrial ferritin plays a crucial protective role post-myocardial infarction by inhibiting ferroptosis, thereby limiting infarct size and reducing the vulnerability to malignant ventricular arrhythmias.
Ferroptosis inhibition may reduce post-MI VAs in animal models; leaves open whether FtMt modulation offers a human therapeutic target.
Post-myocardial infarction ventricular arrhythmias are a leading cause of sudden cardiac death (SCD) following acute myocardial infarction worldwide. Emerging evidence suggests that ferroptosis, an iron-dependent form of cell death, plays a significant role in myocardial infarction damage. While mitochondrial ferritin (FtMt) is known to encapsulate harmful ferrous ions within mitochondria, its role in the development of post-myocardial infarction ventricular arrhythmias (post-MI VAs) is not well understood. This study aimed to clarify the role and mechanisms by which FtMt-mediated ferroptosis influences susceptibility to post-MI VAs. Mice were subjected to permanent ligation of the left anterior descending artery (LAD) to induce myocardial infarction (MI), followed by intracardiac electrophysiological studies to evaluate their vulnerability to post-MI VAs. Patch-clamp recordings and confocal Ca 2+ imaging provided data on neonatal rat ventricular myocytes (NRVMs). We utilized DCFH-DA staining, transmission electron microscopy, and Seahorse analysis to examine the mitochondrial bioenergetics and oxidative phosphorylation in NRVMs. Ferroptosis was activated in mice post-MI. Inhibiting ferroptosis enhanced cardiac function and reduced the incidence of post-MI VAs. Hypoxia led to electrophysiological dysregulation in NRVMs, which was exacerbated by FtMt inhibition. Specifically, FtMt inhibition under hypoxic conditions further impaired mitochondrial bioenergetics and oxidative phosphorylation, promoting ferroptosis in NRVMs. FtMt plays a crucial protective function in MI by limiting infarct size, decreasing the frequency of ventricular arrhythmias, and inhibiting ferroptosis both in vivo and in vitro. These results suggest that FtMt may be a viable therapeutic target for treating MI. • Inhibition of ferroptosis reduces the vulnerability to malignant post-myocardial infarction ventricular arrhythmias. • Inhibition of mitochondrial ferritin aggravates electrophysiological remodeling after myocardial infarction. • Mitochondrial ferritin regulates ferroptosis through the oxidative phosphorylation pathway.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: